RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23591791http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23591791http://www.w3.org/2000/01/rdf-schema#comment"TCL1 oncogene is overexpressed in aggressive form of human chronic lymphocytic leukemia (CLL) and its dysregulation in mouse B cells causes a CD5-positive leukemia similar to the aggressive form of human CLLs. To identify oncogenes that cooperate with Tcl1, we performed genetic screen in Eμ-TCL1 mice using Sleeping Beauty transposon-mediated mutagenesis. Analysis of transposon common insertion sites identified 7 genes activated by transposon insertions. Overexpression of these genes in mouse CLL was confirmed by real time reverse transcription-polymerase chain reaction. Interestingly, the main known function of 4 of 7 genes (Nfkb1, Tab2, Map3K14, and Nfkbid) is participation in or activation of the nuclear factor-kB (NF-kB) pathway. In addition, activation of the NF-kB is 1 of main functions of Akt2, also identified in the screen. These findings demonstrate cooperation of Tcl1 and the NF-kB pathway in the pathogenesis of aggressive CLL. Identification cooperating cancer genes will result in the development of combinatorial therapies to treat CLL."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.org/dc/terms/identifier"doi:10.1182/blood-2013-02-486035"xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Burch A."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Croce C.M."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Pekarsky Y."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Palamarchuk A."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Zanesi N."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Dupuy A.J."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Lagana A."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Rizzotto L."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Balatti V."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Cascione L."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/author"Riordan J."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/pages"4355-4358"xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/title"A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model."xsd:string
http://purl.uniprot.org/citations/23591791http://purl.uniprot.org/core/volume"121"xsd:string
http://purl.uniprot.org/citations/23591791http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23591791
http://purl.uniprot.org/citations/23591791http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23591791
http://purl.uniprot.org/uniprot/#_A0A0G2JGK6-mappedCitation-23591791http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23591791
http://purl.uniprot.org/uniprot/#_A0A0X1KG58-mappedCitation-23591791http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23591791
http://purl.uniprot.org/uniprot/#_H3BJ18-mappedCitation-23591791http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23591791
http://purl.uniprot.org/uniprot/#_H3BJA0-mappedCitation-23591791http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23591791